Homology Medicines, Inc. (FIXX) Misses Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts FIXX Hot Sheet
Join SI Premium – FREE
Homology Medicines, Inc. (NASDAQ: FIXX) reported Q3 EPS of ($0.57), $0.14 worse than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Homology Medicines, Inc. (FIXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
- Yatsen Holding (YSG) Reports Q2 Loss of $0.16
- Credo Technology Group Holding (CRDO) Tops Q1 EPS by 4c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
